(Q39881409)

15 September 2017

title

Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy (English)

1 reference

15 September 2017

0 references

arterial hypertension

0 references

0 references

1 reference

4

1 reference

15 September 2017

1

Eberhard Wille

1 reference

15 September 2017

7

David Jeffries

1 reference

15 September 2017

Jürgen Scholze

2

1 reference

15 September 2017

Eduardo Alegria

3

1 reference

15 September 2017

Sue Langham

5

1 reference

15 September 2017

Warren Stevens

6

1 reference

15 September 2017

Kerstin Uhl-Hochgraeber

8

1 reference

15 September 2017

publication date

20 April 2010

1 reference

The European Journal of Health Economics

15 September 2017

published in

1 reference

15 September 2017

volume

12

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

205-218

1 reference

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Comparison of serum lipid values in subjects with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Revealing the cost of Type II diabetes in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Health care utilization and costs by metabolic syndrome risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Economics and obesity: costing the problem or evaluating solutions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

New treatment strategies for patients with hypertension and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

The metabolic syndrome in hypertension: European society of hypertension position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Acute coronary syndromes in Europe: 1-year costs and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Comparisons of Hypertension-Related Costs from Multinational Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0223-9

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

12 December 2020

Blood pressure control in Italy: results of recent surveys on hypertension

1 reference

12 December 2020

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary

1 reference

12 December 2020

Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population

1 reference

12 December 2020

Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases.

1 reference

12 December 2020

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

1 reference

12 December 2020

Obesity prevalence from a European perspective: a systematic review

1 reference

12 December 2020

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy

1 reference

12 December 2020

Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.

1 reference

12 December 2020

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study

1 reference

12 December 2020

Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe

1 reference

12 December 2020

Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study

1 reference

12 December 2020

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Adherence in chronic disease

1 reference

12 December 2020

Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies

1 reference

12 December 2020

Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study

1 reference

12 December 2020

[Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population]

1 reference

12 December 2020

The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke

1 reference

12 December 2020

Long-term cost and life-expectancy consequences of hypertension

1 reference

12 December 2020

Should Hypertension Guidelines Be Changed for Hypertensive Patients With the Metabolic Syndrome?

1 reference

12 December 2020

Cost of hypertension in Spain

1 reference

12 December 2020

Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study

1 reference

12 December 2020

Undiagnosed obesity in hypertension: clinical and therapeutic implications

1 reference

12 December 2020

Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis

1 reference

12 December 2020

Persistence with treatment for hypertension in actual practice

1 reference

12 December 2020

10.1007/S10198-010-0223-9

Identifiers

DOI

1 reference

15 September 2017

1 reference